A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:
Back to home » Top Stories » CROI 2010
17th Conference on Retroviruses and Opportunistic Infections
CROI 2010 17th Conference on Retroviruses and Opportunistic Infections
Moscone Center West
San Francisco, CA
February 16-19, 2010

Bone Fracture Risk Higher Among People Living With HIV

February 25, 2010

By Tim Horn

People living with HIV face a higher risk of bone fractures than people of similar ages in the general population, according to data from the U.S. Centers for Disease Control and Prevention’s (CDC’s) HIV Outpatient Study (HOPS) presented Thursday, February 18, at the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.

Though there has been no shortage of data indicating that people living with HIV are more likely to have decreased bone mineral density (BMD)—osteopenia and, when more serious, osteoporosis—compared with HIV-negative people of similar ages, it hasn’t been clear that HIV-positive people with bone loss are any more likely to experience serious fractures. Considering that HIV-positive people with osteoporosis are generally younger than those with bone mineral loss in the general population, they are generally believed to be less prone to accidents—which often stem from reduced strength, balance problems and poor dexterity—than elderly adults.

Unfortunately, new data reported by Christine Dao, MPH, of the CDC and her colleagues indicate that people living with HIV do, in fact, face a higher risk of bone fractures, notably at “fragility” sites—the spine (vertebrae), the hip and the wrist—than age-matched individuals in the general population.

HOPS has been following HIV-positive individuals since 1993, making it one of the longest and most comprehensive cohorts of people living with HIV being conducted in the United States.  Ten sites in eight U.S. cities are participating in the study.
Dao’s team compared fracture rates in the HOPS with fracture rates in the adult general population, drawing upon data from the National Hospital Discharge Survey (hospitalized patients) and the National Hospital Ambulatory Medicare Care Survey (outpatients).

Of the 5,826 patients in the HOPS cohort—79 percent of whom were male, their average age was 40, and 73 percent were receiving antiretroviral therapy—a total of 236 fractures were documented between 2000 and 2008. HOPS volunteers who experienced fractures were on average 45 years old at the time, 51 percent of whom were on ARV therapy.

Dao explained that this translated in a higher fracture rate among HOPS participants, compared with the general population, among adults 25 to 54 years old.

She also said that rates of fractures requiring hospitalization have been increasing among HOPS participants. Whereas there were 110 fractures requiring hospitalization per 10,000 HIV-positive individuals in 2000, the rate was 160 per 10,000 in 2008. This difference was statistically significant, meaning it wasn’t likely due to chance. In the National Hospital Discharge Survey, however, the rate of fractures in the general population remained consistent: 25 per 10,000 from 2000 to 2006.

Rates of fractures, treated on an outpatient basis, were also increasing among HOPS participants: 60 per 10,000 in 2000 compared with 85 per 10,000 in 2008. Here, too, the difference was statistically significant. In the general population, the rate remained stable—35 per 10,000 people—from 2000 to 2006.

Fragility fractures were more likely to be documented among HOPS patients compared with those in the general population. For example, vertebrae fractures were documented in 10 percent of HIV-positive men and 18 percent of HIV-positive women between 2000 and 2006, compared with 1 percent and 4 percent of men and women in the general population. Conversely, non-fragility fractures remained more common among those in the general population compared with the HIV-positive individuals participating in HOPS.

As for risk fractures among people living with HIV, those with a lowest-ever (nadir) CD4 count of fewer than 200 cells, coinfection with hepatitis C virus, diabetes and a history of substance abuse were more likely to experience a fracture. The researchers did not measure the severity of bone mineral density loss, as it relates to fracture risk.

In conclusion, Dao pointed out that the actual number of fractures in HOPS has been low. However, she said, the rates are clearly higher among people living with HIV than in the general U.S. population, particularly among younger adults. There are likely a number of reasons why bone fracture rates—notably fragility bone breaks—are higher among people living with HIV, all of which, Dao said, should be explored in greater detail.

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       

More from CROI 2010

HIV/AIDS Complications

March 9, 2010
HIV and the Brain: Part 2
March 8, 2010
Cancer Risks and HIV
HIV and the Brain: Part 1
March 1, 2010
HIV and Bone Health
February 25, 2010
Bone Fracture Risk Higher Among People Living With HIV
Vitamin D Deficiency Common Among HIV Positive
February 24, 2010
HIV in the Brain Usually Matches Levels in the Blood
Hep C Treatment Might Also Guard Against HIV Disease Progression
February 23, 2010
Truvada and Norvir-Boosted Reyataz More Likely to Cause Bone Loss in ACTG Study
Maintaining Higher CD4s Protects Against Brain Damage
February 20, 2010
HIV and Heart Disease Risks
February 19, 2010
Increased Risk of Chronic Kidney Disease Linked to Tenofovir and Atazanavir
Non-AIDS Cancer Risk Decreases With Higher CD4 Cell Counts
Smoking Cessation Reduces Cardiovascular Disease Risk in HIV
February 18, 2010
H1N1 Meets HIV
HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking

HIV Transmission and Prevention

March 8, 2010
HIV Prevention: On the Verge of Success?
HIV Treatment in Southern Africa
March 1, 2010
One in Six New HIV Cases Involves Drug-Resistant Virus
February 22, 2010
Routine HIV Testing Proving Successful in Washington, DC
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies

Starting and Switching Treatment

March 2, 2010
Normal Life Expectancy With Maintenance of CD4s Above 500
February 22, 2010
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies
February 19, 2010
No Efficacy Differences in ACTG Study Comparing Sustiva or Reyataz with either Epzicom or Truvada
February 18, 2010
Once-Daily Prezista Effective, Safer for HIV Treatment-Experienced Patients

Experimental HIV Drugs

March 9, 2010
New Treatments for HIV: Part 1
New Treatments for HIV: Part 2
February 18, 2010
New CCR5 Antagonist Shows Promise in Early Study
Vicriviroc Falls Short in Treatment-Experienced HIV Studies
February 17, 2010
Quad Pill and Boosting Drug Show Well in Studies


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.